BioSpace News Archive

Drug Development

ExThera Announces Completion of Phase I OSCAR I Trial

September 25, 2024
·
5 min read
Business

Avidity Biosciences to Participate in Upcoming Investor Conference

September 25, 2024
·
1 min read
Drug Development

MesoPher Cell Therapy Increases 2-Year RFS Rate in Resected Pancreatic Cancer by 50%; Amphera Announces Publication of Phase II Results in Journal of Clinical Oncology and Orphan Designation Granted by FDA & EMA

September 25, 2024
·
2 min read
Business

Ocular Therapeutix™ to Present at the UBS Virtual Ophthalmology Day 2024

September 25, 2024
·
1 min read
Press Releases

INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society

--Data will be presented at the conference in October in Montreal

September 25, 2024
·
3 min read
FDA

EydisBio Receives FDA Orphan Drug Designation for TAK1 Inhibitor for the Treatment of Systemic Sclerosis

September 25, 2024
·
3 min read
Business

Multiple Myeloma Research Foundation (MMRF) Presents New Data from Multiple Myeloma Research Programs at the 21st International Myeloma Society Annual Meeting

September 25, 2024
·
5 min read
Press Releases

Freenome Announces CEO Transition

September 25, 2024
·
2 min read
FDA

Fujirebio Submits FDA Regulatory Filing for Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease

September 25, 2024
·
3 min read